News

Home/ News & Events

The ESID Elections 2022 are Now Open!

The ESID Elections 2022 are Now Open and you can cast your vote online!

The Inborn Errors WP Annual Meeting will take place in Paris, France, September 23-25th 2022!

This year, the annual meeting of the Inborn Errors Working Party (IEWP) will be happening in Paris, France, September 23-25th 2022 as a face-to-face event.

Call for participation: Malignancies in IEI – an ESID registry study

ESID registry Working Party is inviting the ESID registry participants to take part in the "Malignancies in IEI" study latest by August 31st 2022.

"Call for participation" IDDA2.1 score - an ESID registry prospective study

The IDDA score has already been available as optional module (tab) in the level 1 for your own use at the initial and follow up patient entries and is designed for all IEI with immune dysregulation. Now, I am inviting your active contribution to a prospective study until end of 2023 (prolongation possible), aiming to implement a powerful tool for assessment and monitoring of disease activity and phenotype patterns!

ESID COVID-19 Statement, March 2022

Since the start of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there has been rapid progress with understanding disease, clinical phenotypes and biology, improving treatment and implementing vaccination trials. Data is accumulating about the impact of COVID-19 for patients with Inborn Errors of Immunity (IEI). The purpose of this statement is to summarise our state of knowledge and set out ESID’s current guidance for professionals in the IEI community in Europe. We will update this statement as evidence emerges.

ESID Position Statement

ESID Position Statement

Joint statement of solidarity and support

ESID is profoundly concerned about the grave repercussions of the conflict in Ukraine on PID community, healthcare and patients. 

Together with IPOPI, INGID and J Project stakeholders, we have released a statement of solidarity and support to those impacted by the war in Ukraine.

Hyper IgM Grant opportunity

ESID is pleased to announce an excellent grant funding opportunity

Study on clinical course of IPEX patients infected with SARS-CoV-2

Call for international contributions relating to IPEX patients infected with SARS-CoV-2.

X-Linked Carrier Survey is now open

The Hyper IgM Foundation and the Wiskott-Aldrich Foundation’s first-ever international 

X-Linked Carrier Surveys are now available! We are excited to launch this survey project in collaboration with the Primary Immune Deficiency Treatment Consortium (PIDTC) and the Immune Deficiency Foundation (IDF).